Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEORAL vs NEOSTIGMINE METHYLSULFATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NEORAL vs NEOSTIGMINE METHYLSULFATE: Safety Overview

Metric NEORAL NEOSTIGMINE METHYLSULFATE
Total FAERS Reports 258 344
Deaths Reported 49 11
Death Rate 19.0% 3.2%
Hospitalizations 132 102
Average Patient Age 54.8 yrs 44.7 yrs
% Female Patients N/A 50.5%
FDA Approval Date N/A Apr 20, 2021
Manufacturer N/A Fresenius Kabi USA, LLC
Route N/A INTRAVENOUS
Marketing Status N/A Prescription